)
DATE (ALDAT) investor relations material
DATE H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
H1 2026 revenue rose 16.4% YoY to €1.346M; EBITDA improved to -€9K and net income turned positive at €37K despite seasonally back-loaded deliveries.
The 2026 revenue target of €5–6M, excluding SOFILEMA-NMGP, was reaffirmed; the September IPO and October acquisition support industrial and international expansion.
Financial highlights
Revenue was €1.346M vs €1.156M in H1 2025, up 16.4% YoY; reported revenue mix was 59% Defense and 41% Deep Tech.
EBITDA was -€9K vs -€30K; operating loss improved to €43K from €117K, and net income was €37K vs a €36K loss.
Net income included an €81K income tax benefit, including €70K of research tax credit; net depreciation and provisions were €33K vs €86K YoY.
Outlook and guidance
FY 2026 revenue guidance remains €5–6M, excluding SOFILEMA-NMGP, on expected H2 delivery concentration and commercial visibility at end-June.
At end-June, €4.2M of business was identified for delivery and revenue recognition by year-end, with a further ~€0.6M of potential orders in commercial discussions.
2030 ambitions are revenue above €35M and EBITDA margin above 30%.
)
)
)
)
)
)
)
)